Feb. 11, 2022
NRx Reports Remarks by Israel Institute for Biological Research on the future of the BriLife™ Covid-19 Investigational Vaccine
NRx Pharmaceuticals reported remarks by Dr. Shmuel Yitzhaki, Director of the Israel Institute for Biological Research, on the future of the BriLife™ Covid-19 Investigational Vaccine.